Liquid biopsy study for advanced lung or colon cancer
Part of Cancer, Digestive system, Lungs & breathing clinical trials.
This study is testing a simple blood draw (liquid biopsy) to track advanced lung or colon cancer. It may help doctors understand the cancer better without needing repeated tissue biopsies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have stage IV non-small cell lung cancer (adenocarcinoma) or stage IV colorectal cancer (adenocarcinoma)
- You have not received any cancer treatment yet (chemotherapy, immunotherapy, targeted therapy, or radiation)
- You are able to care for yourself (ECOG score 0-2) and expected to live at least 3 months
- You have not had any other cancer in the last 5 years (except for non-melanoma skin cancer)
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a blood test (liquid biopsy) can help doctors better understand your lung cancer and plan your treatment. You'll have a blood sample taken alongside standard biopsies to see if the blood test provides useful information about your cancer.
This study checks whether “liquid biopsies” (blood tests) can help monitor advanced non-small-cell lung cancer. It looks at different patient groups based on timing and tumor features, aiming to make cancer tracking easier and less invasive.
This study tests whether a simple blood sample from your finger can detect tumor DNA as well as a standard blood draw. It is designed for people with colorectal cancer that has spread to the liver and hasn't responded to treatment.
This study collects blood and may also use existing tumor tissue to help develop a liquid biopsy blood test for people with solid (non-blood) cancers. You may qualify if you have a current cancer with tumor in the body and can provide blood samples at set visits.
This study uses a simple blood test (liquid biopsy) to find early signs of lung cancer in people who are at risk. It aims to catch lung cancer earlier, when it may be easier to treat.
This study uses a simple blood test (liquid biopsy) to look for tiny bits of cancer DNA after surgery for colorectal cancer that spread to the liver. It aims to see if this test can find cancer earlier than standard scans, which may help guide future treatment decisions.
Hear when a new Colorectal Cancer (CRC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.